Neogen - 37 Year Stock Price History | NEOG
Historical daily share price chart and data for Neogen since 1989 adjusted for splits and dividends. The latest closing stock price for Neogen as of March 11, 2026 is 9.86.
- The all-time high Neogen stock closing price was 48.34 on April 20, 2021.
- The Neogen 52-week high stock price is 11.43, which is 15.9% above the current share price.
- The Neogen 52-week low stock price is 3.87, which is 60.8% below the current share price.
- The average Neogen stock price for the last 52 weeks is 6.76.
| Neogen Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 10.0924 | 7.0000 | 11.3300 | 7.0000 | 9.8600 | 41.06% |
| 2025 | 6.9152 | 11.9400 | 13.0700 | 4.3900 | 6.9900 | -42.42% |
| 2024 | 15.2603 | 20.3500 | 20.3500 | 11.6100 | 12.1400 | -39.63% |
| 2023 | 18.8983 | 15.2600 | 23.8400 | 14.6500 | 20.1100 | 32.04% |
| 2022 | 24.2175 | 44.3700 | 44.3700 | 10.7900 | 15.2300 | -66.46% |
| 2021 | 43.6165 | 39.2050 | 48.3350 | 38.8500 | 45.4100 | 14.53% |
| 2020 | 35.5405 | 32.4400 | 40.9450 | 27.0100 | 39.6500 | 21.51% |
| 2019 | 31.8256 | 28.4550 | 39.4000 | 27.0800 | 32.6300 | 14.49% |
| 2018 | 35.2733 | 30.0800 | 48.2500 | 26.3600 | 28.5000 | -7.55% |
| 2017 | 26.1116 | 24.6406 | 31.6154 | 22.3719 | 30.8280 | 24.56% |
| 2016 | 20.3295 | 20.4895 | 25.4544 | 16.7321 | 24.7494 | 16.77% |
| 2015 | 18.9408 | 18.2920 | 22.7432 | 15.8883 | 21.1945 | 13.97% |
| 2014 | 15.8518 | 16.5821 | 18.5958 | 13.6159 | 18.5958 | 8.51% |
| 2013 | 14.2022 | 11.3997 | 19.0795 | 11.3272 | 17.1371 | 51.26% |
| 2012 | 9.9331 | 7.8723 | 11.9822 | 7.6523 | 11.3297 | 47.91% |
| 2011 | 9.6023 | 10.5647 | 11.9497 | 7.5348 | 7.6598 | -25.32% |
| 2010 | 7.2717 | 6.0873 | 10.4822 | 5.2174 | 10.2572 | 73.78% |
| 2009 | 4.5314 | 4.3532 | 6.0848 | 2.9883 | 5.9024 | 41.78% |
| 2008 | 4.2641 | 4.4882 | 5.1982 | 3.3316 | 4.1632 | -5.91% |
| 2007 | 3.2961 | 2.5499 | 4.5632 | 2.3611 | 4.4249 | 79.39% |
| 2006 | 2.3283 | 2.2655 | 2.7488 | 1.9422 | 2.4666 | 5.71% |
| 2005 | 1.9005 | 2.4231 | 2.4277 | 1.3889 | 2.3333 | -7.28% |
| 2004 | 2.1390 | 2.3255 | 2.5166 | 1.7588 | 2.5166 | 14.30% |
| 2003 | 1.5409 | 1.2222 | 2.4336 | 1.0604 | 2.2017 | 65.68% |
| 2002 | 1.2592 | 1.6542 | 1.6720 | 1.0213 | 1.3289 | -17.40% |
| 2001 | 1.2687 | 0.7333 | 2.2391 | 0.7333 | 1.6089 | 122.78% |
| 2000 | 0.6007 | 0.4667 | 0.8555 | 0.4611 | 0.7222 | 54.75% |
| 1999 | 0.5995 | 0.6167 | 0.8000 | 0.4444 | 0.4667 | -25.66% |
| 1998 | 0.7798 | 1.0889 | 1.2333 | 0.5111 | 0.6278 | -37.91% |
| 1997 | 0.7961 | 0.6555 | 1.2889 | 0.5778 | 1.0111 | 58.26% |
| 1996 | 0.6142 | 0.4444 | 0.7833 | 0.4222 | 0.6389 | 43.77% |
| 1995 | 0.6012 | 0.5667 | 0.7333 | 0.4333 | 0.4444 | -25.93% |
| 1994 | 0.6662 | 0.4778 | 0.8555 | 0.4778 | 0.6000 | 25.58% |
| 1993 | 0.3301 | 0.2444 | 0.5667 | 0.2111 | 0.4778 | 83.00% |
| 1992 | 0.2943 | 0.2500 | 0.3778 | 0.2278 | 0.2611 | 4.44% |
| 1991 | 0.2495 | 0.2209 | 0.3333 | 0.2000 | 0.2500 | 21.60% |
| 1990 | 0.3744 | 0.5778 | 0.6278 | 0.1278 | 0.2056 | -61.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.380B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |